Smart ECM
RESAcross Sardinia SasEvento 490566 / Edizione 1

XII Edizione: Viaggio nel cuore

Congresso residenziale di cardiologia (XII edizione) ad Alghero, sulle novità controverse in cardiologia: aritmie, scompenso cardiaco, aterosclerosi, coronaropatia, ipertensione polmonare, valvulopatie, cardiopatie strutturali, elettrofisiologia e interventistica.

Provider
Across Sardinia SasAcross Sardinia Sas (311)
Crediti ECM
5,1
Costo
600,00 €
Durata
17 ore
Date
1 - 3 ottobre 2026

Razionale scientifico

Argomenti del corso: Aritmie, Scompenso Cardiaco, Aterosclerosi, Malattia Coronarica, Ipertensione arteriosa, Ipertensione polmonare, Valvulopatie, Cardiopatie strutturali, Scompenso Cardiaco, Interventistica coronarica e strutturale, Elettrofisiologia e Elettrostimolazione; Organizzazione sanitaria e Medicina Legale. Acquisire conoscenze sulla fisiopatologia e sul trattamento delle più complesse patologie cardiovascolari, della ipertensione polmonare, sulla gestione dello scompenso cardiaco avanzato, sul trattamento delle aritmie atriali e ventricolari e sulle nuove metodiche diagnostiche ed interventistiche.

Luogo

Hotel Catalunya
Via Catalogna 22, Alghero (SS)

Programma

Giovedì 1 ottobre - Main Session (Catalunya Room)· Hotel Catalunya, Alghero - Catalunya Room
  • 10.00-13.45I SESSION: OBESITY, DIABETES AND LIPIDIC METABOLISM – PART 1
  • 10.00Mechanisms underlying obesityLeonardo De Luca
  • 10.15Obesity and cardiovascular healthFederico Nardi
  • 10.30Tirzepatide for Obesity Treatment and Diabetes PreventionGiuseppe Patti
  • 10.45Semaglutide for the treatment of obesityClaudio Bilato
  • 11.00Novel Targets and therapeutic agent in diabetes mellitusAngelo Avogaro
  • 11.15Discussion
  • 11.15-13.30OBESITY, DIABETES AND LIPIDIC METABOLISM – PART 2
  • 11.30Homozygous Familial HypercholesterolemiaMaurizio Averna
  • 11.45Autosomal recessive hypercholesterolemiaMarcello Arca
  • 12.00Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and TreatmentAlberigo Catapano
  • 12.15Inclisiran in HypercholesterolemiaPasquale Perrone Filardi
  • 12.30Bempedoic Acid: for Whom and WhenAlberto Corsini
  • 12.45Icosapent etile: new opportunity or false hope?Alberto Zambon
  • 13.00Efficacy of Lomitapide and Evinacumab in the treatment of homozygous familial hypercholesterolemiaLaura D'Erasmo
  • 13.15PCSK9 Inhibitors the present and the futurePiera Angelica Merlini
  • 13.30Discussion
  • 13.45Lunch
  • 14.30-19.00II SESSION: PULMONARY HYPERTENSION
  • 14.30Pulmonary arterial Hypertension: haemodynamic definition and clinical classificationDario Vizza
  • 14.45Right ventricular phenotyping in idiopathic pulmonary hypertensionStefano Ghio
  • 15.00Right ventricular function in PAHSilvia Papa
  • 15.15Advanced in medical therapy for PAHEmanuele Romeo
  • 15.30Post Capillary Pulmonary HypertensionRaymond Benza
  • 15.45Pulmonary hypertension in interstitial lung diseaseDavid Montani
  • 16.00Overview of the Treatment of Chronic Thromboembolic Pulmonary HypertensionAndrea D'Armini
  • 16.15Sotatercept for the Treatment of Pulmonary Arterial HypertensionLaurent Savale
  • 16.30Pulmonary veno-occlusive diseaseSabina Solinas
  • 16.45Discussion
  • 17.00-19.00III SESSION: HEART FAILURE
  • 17.00Old and New Drugs for Heart FailureMichele Senni
  • 17.15Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection FractionSavina Nodari
  • 17.30Effects of SGLT2 Inhibitors on Kidney and Cardiovascular FunctionNadia Aspromonte
  • 17.45SGLT2 inhibitor: the key of immortality?Gennaro Cice
  • 18.00Diabetic Cardiomyopathy: What Clinicians Should KnowDomenico Gabrielli
  • 18.15Overlap between myocarditis and dilated or arrhythmogenic cardiomyopathiesGianfranco Sinagra
  • 18.30Mechanical circulatory support devices in advanced heart failureFabrizio Oliva
  • 18.45Surgical Approaches in Heart FailureBastian Schmack
  • 19.00Discussion
  • 19.15End of the day
Venerdì 2 ottobre - Main Session (Catalunya Room)· Hotel Catalunya, Alghero - Catalunya Room
  • 09.00-11.30IV SESSION: VALVULOPATHIES – PART 1
  • 09.00LECTURE: Mitral valve regurgitationRaluca Elena Dulgheru
  • 09.30Mitral valve surgery: current status and future perspectives of the minimally invasive approachDaniel Pereda
  • 09.45Transcatheter Mitral Valve Repair Therapies: Evolution, Status and ChallengesFausto Castriota
  • 10.00LECTURE: Tricuspid valve regurgitationItalo Porto
  • 10.30Contemporary Outcomes of Isolated Tricuspid Valve SurgeryMarco di Eusanio
  • 10.45Managing Complex Anatomical Scenarios in TAVIGiuseppe Tarantini
  • 11.00Complication in TAVI procedure: risk factors and current approachesGiuseppe Musumeci
  • 11.15TAVI Age-Based Recommendation 2025 ESC-EACTS: a critical point of viewPaolo Centofanti
  • 11.30Discussion
  • 11.45-13.45V SESSION: IMAGING IN INTERVENTIONAL CARDIOLOGY
  • 11.45CT-driven structural intervention: from anatomy to strategiesSergio Berti
  • 12.00Role of Echocardiography in pre-procedural planning and intraprocedural guidingNazario Carrabba
  • 12.15Artificial Intelligence in interventional cardiologyFrancesco Meucci
  • 12.30Cardiac magnetic resonance: is there a relevant role in interventional procedures?Gianluca Pontone
  • 12.45Cardiac digital twin solutions for research and clinical decision supportJoost Lumens
  • 13.00Discussion
  • 13.15LECTURE: UP TO DATE: Team working and cardiac care outcomeDavide Pacini
  • 13.45Light Lunch
  • 14.30LECTURE: Anatomy of the atrial septum, interatrial communications and left atrial appendageGaetano Thiene
  • 15.00-15.45VI SESSION: STRUCTURAL DISEASE
  • 15.00PFO closure in daily practicePaolo Scacciatella
  • 15.15Migraine in patients undergoing PFO closureAchille Gaspardone
  • 15.30New perspective in LAAoCarmelo Grasso
  • 15.45Discussion
  • 16.00-17.15VI SESSION: CARDIOMYOPATHIES
  • 16.00Hypercontractile phenotype: from pathophysiological rationale to clinical evidence in HFpEF and HCMIacopo Olivotto
  • 16.15Pharmacological treatment of HCM with cardiac myosin inhibitors: real-world dataMaurizio Pieroni
  • 16.30The changing landscape of amyloidosis: AL vs ATTR, current and emerging therapiesFrancesco Cappelli
  • 16.45Overlap between myocarditis and dilated or arrhythmogenic cardiomyopathiesGianfranco Sinagra
  • 16.45Fabry disease - screening strategies in the era of replacement and chaperone therapyAlessia Argiro
  • 17.00Discussion
  • 17.30-18.15VII SESSION: INTERVENTIONAL CARDIOLOGY IN PEDIATRIC PATIENTS
  • 17.30Percutaneous approaches in GUCHMassimo Chessa
  • 17.45Pharmacological and non pharmacological therapies in neonatal and pediatric arrhythmiasFabrizio Drago
  • 18.00Discussion
  • 18.15End of the Day
Sabato 3 ottobre - Main Session (Catalunya Room)· Hotel Catalunya, Alghero - Catalunya Room
  • 09.00-10.15VIII SESSION: CORONARY DISEASE
  • 09.00Left ventricular assist devices for high-risk percutaneous coronary interventionFrancesco Saia
  • 09.15Small vessel diseaseMarco Zimarino
  • 09.30Spontaneous coronary dissectionFerdinando Varbella
  • 09.45Vulnerable Coronary Plaque: Advances in Detection and ManagementFrancesco Prati
  • 10.00Microvascular Angina: State of the ArtGianluca Campo
  • 10.15Antithrombotic drugs for acute coronary syndrome in womenAndrea Rubboli
  • 10.30-13.00IX SESSION: SUDDEN DEATH AND PACING
  • 10.30Impact of gene therapies in the treatment of cardiomyopathies and channelopathiesSilvia Priori
  • 10.45Arrhythmogenic CardiomyopathyMarika Martini
  • 11.00Brugada syndrome in 2025: redefining diagnosis and clinical risk stratificationGiuseppe Ciconte
  • 11.15Risk stratification in inherited arrhythmia syndromes (CPVT, LQTS)Moises Rodriguez Manero
  • 11.30Unexplained sudden cardiac death and idiopathic VF: diagnosis and treatmentGiulio Conte
  • 11.45Predicting sudden death in genetic cardiomyopathy with preserved systolic functionPaolo Della Bella
  • 12.00Alternative site pacing to improve cardiac functionFrancesco Zanon
  • 12.15New perspectives on device therapy in primary electrical diseasesLeonardo Calo
  • 12.30Discussion
  • 13.00End of The Conference
Giovedì 1 ottobre - Sala Mimosa (Aritmologia)· Hotel Catalunya, Alghero - Sala Mimosa
  • 10.00Initial Evaluation and Differential Diagnosis - Reflex SyncopeMichele Brignole
  • 10.15Cardiac pacing in reflex syncopeMarco Tomaino
  • 10.30Neurocardioablation in reflex syncope: How to select the appropriate candidateErmenegildo De Ruvo
  • 10.45Neurocardioablation in reflex syncope: Procedural insights, durability and safetyDan Wichterle
  • 11.00Discussion
  • 11.15Atrial fibrillation in young patients: when is it an ominous sign?Domenico Caponi
  • 11.30AF and wearableRaimondo Pittorru
  • 11.45Should we Ablate Asymptomatic Atrial Fibrillation?Giulio Molon
  • 12.00After two years... has PFA really changed AF outcomes?Laura Cipolletta
  • 12.15Why to use ICE for AF ablationPetr Peichl
  • 12.30Discussion
  • 13.00Lunch
  • 14.00CT vs MRI for definition of scar substrates and emerging role of photon counting CTFilippo Cauti
  • 14.15Cardiac Imaging with Photon Counting CTStefano Pala
  • 14.30The role of His-Purkinje System in ventricular arrhythmiasLivio Bertagnolli
  • 14.45VT ablation: innovation in energy sourcesPetr Peichl
  • 15.00Epicardial approach: EHRA/HRS/APHRS/LAHRS/CHRS Clinical Consensus StatementPaolo Della Bella
  • 15.15Interactive ECG session: practical issues in everyday ECG interpretationLeonardo Calo
  • 15.30Discussion
  • 15.45How to prevent CIED infectionMatteo Ziacchi
  • 16.00Early detection and treatment of infected CIED patientsMaria Grazia Bongiorni
  • 16.15Indication for lead extraction beyond infectionsAntonio Curnis
  • 16.30How to plan my lead extraction: the role of multidisciplinary teamFederico Migliore
  • 16.45When and what to implant after lead extraction?Patrizio Mazzone
  • 17.00Management CIEDs infectionAndrea Droghetti
  • 17.15Wearable cardioverter-defibrillator: friend or foe?Giulio Molon
  • 17.30Discussion
Venerdì 2 ottobre - Sala Mimosa (Cardiologia Interventistica)· Hotel Catalunya, Alghero - Sala Mimosa
  • 08.45Live Case from Sassari Cath LabPierluigi Merella, Marta Casula, Gabriele Luigi Gasparini
  • 10.00Discussion
  • 10.20OCT: Histopathological correlationsAlberto Boi
  • 10.40OCT: PCI optimizationPaolo Canova
  • 11.00OCT-guided PCI: a step-by-step practical caseFilomena Sechi
  • 11.15Discussion
  • 11.30Severe calcified lesion: contemporary approachGiacomo Boccuzzi
  • 11.50Identification and interventional treatment of coronary calcified nodulesFabrizio Ugo
  • 12.10Plaque debulking: when atherectomy, when lithotripsyAlberto Menozzi
  • 12.30LASER-PCI: when and howRocco Sclafani
  • 12.50Panel discussion and audience Q&A
  • 13.15Lunch
  • 14.30LECTURE: IVUS: a practical guide to interpretationGabriele Gasparini
  • 15.00DCB: when and how (from lesion selection to lesion preparation)Massimo Sangiorgi
  • 15.20DCB: imaging to guide the procedureFrancesco Tomassini
  • 15.40DCB: physiology to guide the procedureAntonio Colombo
  • 16.00Discussion
  • 16.15LECTURE: Adjuvant antithrombotic therapy in ST-elevation myocardial infarctionLeonardo Bolognese
  • 16.40DK Crush for distal LM bifurcationMarco Licciardi
  • 17.00DK Culotte stenting for distal LM bifurcationRoberto Sapino
  • 17.20A Medina 0.0.1 Bifurcation: Interventional treatmentAlessandro Fancello
  • 17.40Bifurcation Hybrid revascularizationGiacomo Fanti
  • 18.00An heavy calcific LM bifurcationGianluca Pillitteri
  • 18.20Closing Remarks
Sabato 3 ottobre - Sala Mimosa (Riabilitazione Cardiaca e Telemedicina)· Hotel Catalunya, Alghero - Sala Mimosa
  • 09.00Artificial intelligence, exercise, and prognosis of heart failurePiergiuseppe Agostoni
  • 09.15Role of cardiopulmonary exercise testing for exercise prescription in heart diseasePietro Palermo
  • 09.30Rehabilitation in cardio-oncologyLeopoldo Pagliani
  • 09.45Discussion
  • 10.00Nutritional assessment in patients with heart failureEmanuele Cereda
  • 10.15New frontiers in cardiac rehabilitation: dance, music, and calisthenicsDino della Ventura
  • 10.30How to structure psychological intervention in cardiac patientsPaolo Milia
  • 10.45The importance of sleep in cardiac patientsValerio Brunetti
  • 11.00Discussion
  • 11.15Telemedicine: a vision for the futureAntonio Vittorino Gaddi
  • 11.30Cybersecurity: telemedicine, precision medicine, and digital innovationPietro Di Maria
  • 11.45Digital health and technology transferSaverio Losito
  • 12.00Discussion
  • 12.15ABSTRACT SESSION: Selected Abstract Presentations

Responsabili del corso

ACROSS SARDINIA SAS

Provider

ID Provider: N° 311

Città: Sassari (SS)

Tipologia: Società, Agenzie Ed Enti Privati

Stato accreditamento: Standard - 1° Rinnovo

  • Gavino Casu

    Responsabile scientifico

    Specializzazione: Cardiologia

    Struttura: AOU Sassari

    Ruolo: Direttore S.C. di Cardiologia Clinica ed Interventistica; Direttore Scuola di Specializzazione Malattie dell'Apparato Cardiovascolare, Università di Sassari

  • Michele Portoghese

    Responsabile scientifico

    Specializzazione: Cardiochirurgia

    Struttura: AOU Sassari

    Ruolo: Direttore S.C. di Cardiochirurgia; Direttore del Dipartimento Cardiovascolare

Relatori e docenti

  • Piergiuseppe Agostoni

    Relatore

    Specializzazione: Cardiologia

    Struttura: Centro Cardiologico Monzino, Milano

    Ruolo: Direttore del Dipartimento di Cardiologia Critica e Riabilitativa

  • Marcello Arca

    Relatore

    Specializzazione: Cardiologia

    Struttura: Policlinico Umberto I, Roma

    Ruolo: Professore Ordinario di Medicina Interna, Università La Sapienza

  • Alessia Argiro'

    Relatore

  • Nadia Aspromonte

    Relatore

    Specializzazione: Cardiologia

    Struttura: Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma

    Ruolo: Professoressa e Responsabile PCA Insufficienza Cardiaca

  • Enrico Atzori

    Moderatore

Domande frequenti

L'evento è accreditato per: Medico Chirurgo (Medicina Legale, Medicina Dello Sport, Medicina Nucleare, Geriatria, Nefrologia, Pediatria, Chirurgia Vascolare, Genetica Medica, Malattie Dell'apparato Respiratorio, Cardiochirurgia, Cardiologia, Medicina Interna, Reumatologia, Chirurgia Generale, Anestesia E Rianimazione, Radiodiagnostica, Ematologia, Malattie Metaboliche E Diabetologia, Radioterapia, Anatomia Patologica).

Fonte dati per questo evento: Agenas. Evento organizzato da provider terzo. Smart ECM riporta dati pubblici dell'evento a scopo informativo e non è responsabile né del corso né dei contenuti, né ha accordi commerciali o di collaborazione con il provider.

Sei un provider ECM?

Contattaci per scoprire come possiamo collaborare.

Contattaci